(19)
(11) EP 0 991 665 A1

(12)

(43) Date of publication:
12.04.2000 Bulletin 2000/15

(21) Application number: 97930614.9

(22) Date of filing: 16.06.1997
(51) International Patent Classification (IPC)7C07K 14/715, A61K 38/20, C12N 15/10
(86) International application number:
PCT/GB9701/620
(87) International publication number:
WO 9857/991 (23.12.1998 Gazette 1998/51)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV RO SI

(71) Applicant: GLAXO GROUP LIMITED
Greenford, Middlesex UB6 ONN (GB)

(72) Inventors:
  • BARRETT, Ronald William,Affymax Res. Institute
    Palo Alto, CA 94304 (US)
  • ENGLAND, Bruce Padon,Affymax Research Institute
    Palo Alto, CA 94304 (US)
  • SCHATZ, Peter Joseph,Affymax Research Institute
    Palo Alto, CA 94304 (US)
  • SLOAN, Derek, Dean
    San Diego, CA 92130 (US)
  • CHEN, Min-Jia,Affymax Research Institute
    Palo Alto, CA 94304 (US)

(74) Representative: Teuten, Andrew John et al
Glaxo Wellcome plc,Glaxo Wellcome House,Berkeley Avenue
Greenford,Middlesex UB6 0NN
Greenford,Middlesex UB6 0NN (GB)

   


(54) PEPTIDES AND COMPOUNDS THAT BIND TO THE IL-5 RECEPTOR